Exploring the Immunoresponse in Bladder Cancer Immunotherapy

Exploring the Immunoresponse in Bladder Cancer Immunotherapy

Bladder cancer (BC) represents a wide spectrum of diseases, ranging from recurrent non-invasive tumors to advanced stages that require intensive treatments. BC accounts for an estimated 500,000 new cases and 200,000 deaths worldwide every year. Understanding the biology of BC has changed how this di...

Full description

Saved in:
Bibliographic Details
Main Authors: Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, José Félix Escudero-Bregante, Belén Ferri, José Antonio Campillo, Eduardo Pons-Fuster, María Dolores Martínez Hernández, María Victoria Martínez-Sánchez, Diana Ceballos, Alfredo Minguela
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Cells
Subjects:
bladder cancer
immune response
immunotherapy
BCG
checkpoints
Online Access:https://www.mdpi.com/2073-4409/13/23/1937
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/13/23/1937

Similar Items